BRAF and melanoma: Also, in another study on this topic, plasma ctDNA BRAF V600E/K mutations were analyzed using ddPCR in 19 melanoma patients treated with BRAF/MEKi, and ddPCR negativity was confirmed with ultra-deep sequencing [113].